Ozempic 1 mg Blue Pen – Semaglutide 4 mg/3 ml

Ozempic 1 mg Pre-Filled Pen: Product Overview

Ozempic 1 mg Blue Pen (4 mg Kit) by Novo Nordisk is a prescription medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. The product is supplied as a multidose prefilled injection pen containing 4 mg of semaglutide in 3 ml of solution, with a concentration of 1.34 mg/ml.

The Ozempic 1 mg pen is designed to deliver four individual 1 mg doses. Its blue-label presentation distinguishes it from the lower-strength Ozempic 0.25 mg and 0.5 mg pen and the higher-strength 2 mg pen.

Ozempic belongs to the GLP-1 medication class and is not a human growth hormone (HGH), somatropin or anabolic steroid product. Semaglutide acts on GLP-1 receptors and is used in the medical management of type 2 diabetes and certain associated health risks.

Ozempic 1 mg Blue Pen Product Specifications

• Product Name: Ozempic 1 mg Blue Pen
• Catalog Name: Ozempic 1 mg Dosage Blue (4 mg Kit)
• Brand: Ozempic
• Manufacturer: Novo Nordisk
• Active Ingredient: Semaglutide
• Classification: GLP-1 receptor agonist
• Total Pen Content: 4 mg
• Solution Volume: 3 ml
• Concentration: 1.34 mg/ml
• Delivered Dose: 1 mg
• Number of Doses: Four 1 mg doses
• Product Form: Solution for injection
• Delivery Device: Multidose prefilled pen
• Pen Identification: Blue label
• Administration Route: Subcutaneous injection
• Administration Frequency: Once weekly as prescribed
• Storage Before First Use: Refrigerated at 2°C–8°C
• Prescription Status: Prescription medication

Ozempic Active Ingredient: Semaglutide

Semaglutide is the active pharmaceutical ingredient in Ozempic. It belongs to a class of medications known as glucagon-like peptide-1 receptor agonists.

GLP-1 is a naturally occurring hormone involved in glucose regulation and appetite signaling. Semaglutide mimics certain effects of this hormone through activation of GLP-1 receptors.

Its pharmacological actions include glucose-dependent stimulation of insulin secretion, reduction of inappropriate glucagon secretion and delayed gastric emptying.

Semaglutide also influences appetite and food intake through pathways involved in energy regulation.

Although semaglutide may affect body weight, Ozempic and other semaglutide-containing medications have product-specific approved indications and dosing instructions.

Ozempic 1 mg Blue Pre-Filled Injection Pen

The Ozempic 1 mg Blue Pen is a multidose injection device containing semaglutide solution.

Each pen contains a total of 4 mg semaglutide in 3 ml of liquid formulation. The device is designed to deliver four separate doses of 1 mg.

Ozempic 4 mg Kit: Pen Contents

• One Ozempic multidose prefilled pen
• 4 mg total semaglutide content
• 3 ml injection solution
• Four available 1 mg doses
• 1.34 mg/ml semaglutide concentration
• Four NovoFine Plus needles in the standard US carton
• Manufacturer product instructions

Packaging and included accessories can vary by market. Confirm the contents of the specific product package before relying on the standard US configuration.

Ozempic 1 mg vs 0.25 mg, 0.5 mg and 2 mg Pens

Ozempic is available in different dose presentations. The dose indicated on a pen is not necessarily equal to the total amount of semaglutide contained in the device.

Ozempic 0.25 mg and 0.5 mg Pen

The lower-strength multidose presentation contains 2 mg of semaglutide in 3 ml of solution, with a concentration of 0.68 mg/ml.

Depending on the dose setting, the device is used for 0.25 mg or 0.5 mg injections according to the manufacturer's instructions.

Ozempic 1 mg Blue Pen

The 1 mg presentation contains 4 mg of semaglutide in 3 ml of solution. It delivers four 1 mg doses and is identified by blue labeling in the US presentation.

Ozempic 2 mg Pen

The higher-strength multidose pen contains 8 mg of semaglutide in 3 ml of solution, with a concentration of 2.68 mg/ml. It delivers four 2 mg doses.

Different Ozempic pens have distinct concentrations and dose settings. They should not be considered interchangeable solely because they contain the same active ingredient.

Ozempic 1 mg: Approved Medical Uses

Ozempic is a prescription GLP-1 receptor agonist medication with established uses in adults with type 2 diabetes mellitus.

Its US-approved indications include improving glycemic control alongside diet and exercise, reducing the risk of major adverse cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease, and reducing specified kidney and cardiovascular risks in adults with type 2 diabetes and chronic kidney disease.

Clinical suitability depends on the patient's diagnosis, medical history, other medications and treatment goals.

The 1 mg pen is a specific dose presentation and should not be interpreted as the recommended starting dose for every patient.

Semaglutide Pharmacology and Half-Life

Semaglutide is a long-acting GLP-1 receptor agonist designed for once-weekly administration in its Ozempic injectable formulation.

Semaglutide has an elimination half-life of approximately one week. Its prolonged activity supports the weekly administration schedule established in the manufacturer's prescribing information.

Drug exposure, clinical response and tolerability depend on individual patient characteristics and treatment conditions.

Ozempic 1 mg Pen Storage and Handling

Ozempic is a temperature-sensitive prescription medication.

According to Novo Nordisk's US product instructions:

• Before first use, store refrigerated at 2°C–8°C.
• Do not freeze the medication.
• After first use, the pen may be stored refrigerated or at room temperature between 15°C and 30°C.
• Discard the pen 56 days after first use.
• Protect the medication from excessive heat and direct sunlight.
• Remove and safely discard used needles after each injection.
• Do not share the pen with another person.

Always follow the instructions supplied with the specific product and market presentation.

Ozempic Semaglutide Safety and Precautions

Ozempic requires appropriate medical evaluation and supervision.

Common adverse reactions include nausea, vomiting, diarrhea, abdominal pain and constipation.

Important warnings include pancreatitis, gallbladder disease, dehydration-related kidney injury, diabetic retinopathy complications and hypoglycemia risk when combined with certain glucose-lowering medications.

Ozempic carries a boxed warning concerning thyroid C-cell tumors observed in rodents. It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Patients should consult their healthcare professional and review the current official prescribing information before starting or changing treatment.

Ozempic 1 mg Packaging and Documentation

Review the original product photographs below the main image to examine the Ozempic Blue Pen, manufacturer packaging and product labeling.

Important product identification details include:

• Ozempic brand name
• Novo Nordisk manufacturer identification
• Semaglutide active ingredient
• 1 mg delivered dose
• 4 mg total pen content
• 3 ml solution volume
• 1.34 mg/ml concentration
• Blue-label pen identification
• Batch or lot number
• Expiration date
• Original packaging integrity
• Manufacturer Instructions for Use
• Product-specific storage requirements

The product's current packaging should be verified against the actual supplied item. A historical sample image, label or report does not establish the authenticity or condition of a different package.

Official product information is available from Novo Nordisk Ozempic Prescribing Information.

Frequently Asked Questions About Ozempic 1 mg Pre-Filled Pen

What is Ozempic 1 mg Blue Pen?

Ozempic 1 mg Blue Pen is a Novo Nordisk prefilled multidose injection device containing semaglutide, a GLP-1 receptor agonist. It contains 4 mg of semaglutide in 3 ml of solution and delivers four 1 mg doses.

Who manufactures Ozempic?

Ozempic is manufactured by Novo Nordisk, a pharmaceutical company specializing in diabetes and other chronic disease treatments.

What is the active ingredient in Ozempic?

The active ingredient is semaglutide, a long-acting glucagon-like peptide-1 receptor agonist.

How much semaglutide is in Ozempic 1 mg Pen?

Each 1 mg Blue Pen contains 4 mg of semaglutide in 3 ml of solution, with a concentration of 1.34 mg/ml.

How many 1 mg doses are in the Ozempic Blue Pen?

The standard 4 mg/3 ml Ozempic pen is designed to deliver four individual 1 mg doses.

Is Ozempic 1 mg the same as Ozempic 4 mg?

The terms describe different aspects of the same pen presentation. The 1 mg value identifies the delivered dose, while 4 mg identifies the total semaglutide content in the device.

What does the blue Ozempic pen label mean?

In the standard US multidose pen presentation, blue labeling identifies the Ozempic pen designed to deliver 1 mg doses. Always confirm the strength printed on the current manufacturer label.

Is Ozempic a human growth hormone product?

No. Ozempic contains semaglutide and belongs to the GLP-1 receptor agonist medication class. It does not contain human growth hormone or somatropin.

What is the difference between Ozempic 0.5 mg and 1 mg?

The standard US 0.5 mg multidose pen contains 2 mg in 3 ml, while the 1 mg pen contains 4 mg in 3 ml. They deliver different doses and have different concentrations.

What is the half-life of semaglutide?

Semaglutide has an elimination half-life of approximately one week, supporting the once-weekly administration schedule of Ozempic injections.

Does Ozempic cause gastrointestinal side effects?

Yes. Nausea, vomiting, diarrhea, abdominal pain and constipation are recognized adverse reactions associated with semaglutide treatment.

How should Ozempic 1 mg be stored?

Before first use, Ozempic should be refrigerated at 2°C–8°C. After first use, the pen may be kept refrigerated or at controlled room temperature according to Novo Nordisk's instructions.

How long can Ozempic be used after first use?

The manufacturer's US instructions specify that the multidose pen must be discarded 56 days after first use, even if medication remains.

Does the Ozempic 4 mg kit include needles?

The standard US package includes one multidose pen and four NovoFine Plus needles. Confirm the contents of the specific market presentation.

What should be checked on the Ozempic package?

Confirm the Novo Nordisk label, semaglutide ingredient, 4 mg/3 ml strength, 1 mg dose setting, batch number, expiration date, package integrity and Instructions for Use.

How can I request information about Ozempic 1 mg Pre-Filled Pen?

Use the information request form on this page. The product is attached automatically. Enter your name, country, email and number of packages, and specify any questions about packaging or documentation.

Related Product Guides

• Tirzepatide vs Semaglutide: Which Is Better for Weight Loss?
• Ozempic 6-Week Weight Loss Plan: Results & Timeline
• Semaglutide Peptide Reviews – Benefits, Uses, Safety, and Expert Insights
• HGH and Fat Loss Mechanisms: The Complete Guide to How Growth Hormone Burns Body Fat
• Best Hormone Therapy for Anti Aging
• Semaglutide peptide 5mg
• Jintropin HGH 100IU